Nothing stopped red states from "challenging the scope of FDA’s authority or its decisionmaking" before Dobbs ruling, DOJ says. "We're simply asking DOJ to step aside and let us handle ...

In a landmark decision that challenges the European Commission’s transparency standards, the General Court of the European ...

NGOs and others affected by transparency issues have hailed Wednesday's EU Court of Justice's General Court ruling that the ...

A top European court says the European Commission failed to provide a credible explanation for refusing The New York Times ...

BMO Capital cut Terns Pharmaceuticals' price target from $26 to $15, citing costlier capital conditions despite maintaining ...

A top court on Wednesday ruled that the European Commission had failed the transparency test by declining to release text ...

A top court is to rule Wednesday on whether the EU failed the transparency test by declining to release text messages sent by ...

Pfizer Inc.’s stock rose handily Tuesday after the drug manufacturer said it’s trending toward the higher end of its 2025 profit projections. Pfizer also beat analyst expectations for first ...

The American Chemical Society (ACS) is ending its diversity programme following significant legal and political pressure ... Earlier this year, the group also scored wins with similar lawsuits against ...

Pfizer is actively addressing these challenges through strategic acquisitions and cost efficiencies. The $43 billion acquisition of Seagen in 2023 bolsters its oncology portfolio, adding antibody ...